| Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
|---|---|---|---|---|---|---|
| Mal5g3470 | ATGAGAGGCTACGGGCCACCTACTTCCATTCCATCACAGGCCAGCCACTACCCTACCTTGGGAGTCAACATGTTCCTTCTTAGAAGGCAAACCCAAAATCAGCAGGAGAATGGCTCCTCAAATAATGATACTAAGGTGGCTGAACTAAGAGCTGCTATTGGGCCCTTGTCTGGGCGTCGATTGAAGTATTGCACAGATGCATGTTTAAGGAGATATTTAGAAGCACGAAACTGGAATGTTGATAAAGCCAAGAAAATGCTGGAGGAATCGTTCAAGTGGAGGTCTACTTATAAGCCTGAGGAAATCCGTTGGGCTGAAGTAGCACATGAGGGCGAGACGGGAAAAGTCTCCGTAGCCAACTTTCATGATAGGCTTGGGAGGACAGTGCTTATTATGAGACCAGCGATGCAGAACACAGCATCAGAAGAAAATAATATCAAGCATTTAGTCTATCTGTTGGAAAATGCCATACTCAATCTTTCCGATGGTCAAGAACAAATGTCATGGTTGATAGACTTCACAGGATTTTCATTTAGCACAAAGCTTTCTATTAAAACTGCTCGTGAGATTATTCACATTTTACAGAACCACTATCCGGAAAGGCTTGGTATAGCTATTCTGCACAACCCACCAAGAATATTTCAGGCTTTCTATAAGGCTGTAAAATACTTCATGGACCCCAAGACAGCCCAGAAGGTAAAATTTGTTTACCCTAACAATAAGGACAGTGTGGAGCTGATGAAATCACTCTTTGACATGGATAATCTTCCAAGTGAATTTGGTGGAAAAACTACTTTAAAGTATGACCATGAAGAGTTCTCAAAGTTGATGACTGAAGATGATGGGAAAACTGCCAAGTTCTGGGGACTTGATGATGAGAAGCCCTTCACCACTAAGAATGGCCATTCTGGAGCAGAGGTAGCACCAGAGCCAGTGGCCTAG | 942 | 0.4321 | MRGYGPPTSIPSQASHYPTLGVNMFLLRRQTQNQQENGSSNNDTKVAELRAAIGPLSGRRLKYCTDACLRRYLEARNWNVDKAKKMLEESFKWRSTYKPEEIRWAEVAHEGETGKVSVANFHDRLGRTVLIMRPAMQNTASEENNIKHLVYLLENAILNLSDGQEQMSWLIDFTGFSFSTKLSIKTAREIIHILQNHYPERLGIAILHNPPRIFQAFYKAVKYFMDPKTAQKVKFVYPNNKDSVELMKSLFDMDNLPSEFGGKTTLKYDHEEFSKLMTEDDGKTAKFWGLDDEKPFTTKNGHSGAEVAPEPVA* | 314 |
| Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
|---|---|---|---|---|---|---|---|---|
| Mal5g3470 | 313 | MobiDBLite | consensus disorder prediction | 294 | 313 | - | - | |
| Mal5g3470 | 313 | PRINTS | Cellular retinaldehyde-binding protein signature | 254 | 263 | - | - | |
| Mal5g3470 | 313 | PRINTS | Cellular retinaldehyde-binding protein signature | 185 | 206 | - | - | |
| Mal5g3470 | 313 | PRINTS | Cellular retinaldehyde-binding protein signature | 68 | 90 | - | - | |
| Mal5g3470 | 313 | PRINTS | Cellular retinaldehyde-binding protein signature | 113 | 137 | - | - | |
| Mal5g3470 | 313 | SUPERFAMILY | CRAL/TRIO N-terminal domain | 38 | 105 | IPR036273 | - | |
| Mal5g3470 | 313 | CDD | SEC14 | 122 | 263 | IPR001251 | - | |
| Mal5g3470 | 313 | Pfam | CRAL/TRIO, N-terminal domain | 65 | 89 | IPR011074 | - | |
| Mal5g3470 | 313 | SMART | CRAL_TRIO_N_2 | 65 | 90 | IPR011074 | - | |
| Mal5g3470 | 313 | ProSiteProfiles | CRAL-TRIO lipid binding domain profile. | 106 | 268 | IPR001251 | - | |
| Mal5g3470 | 313 | Gene3D | - | 21 | 295 | IPR036865 | - | |
| Mal5g3470 | 313 | PANTHER | DIVERGENT CRAL/TRIO DOMAIN PROTEIN | 29 | 312 | - | - | |
| Mal5g3470 | 313 | SMART | sec14_4 | 110 | 265 | IPR001251 | - | |
| Mal5g3470 | 313 | PANTHER | GH16843P | 29 | 312 | - | - | |
| Mal5g3470 | 313 | Pfam | CRAL/TRIO domain | 113 | 262 | IPR001251 | - | |
| Mal5g3470 | 313 | SUPERFAMILY | CRAL/TRIO domain | 105 | 277 | IPR036865 | - |
| Select | Gene | Chromosome | Start | End | Duplicated_type |
|---|---|---|---|---|---|
| Mal5g3470 | Mal-Chr5 | 99784913 | 99788432 | Dispersed/Wgd |
| Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
|---|---|---|---|---|---|---|---|---|
| Mal5g3470 | 69 | 257 | Acyl Lipid Metabolism Gene Families | AT1G55840 | 26.341 | 2.74e-09 | 55.5 |
| Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
|---|---|---|---|---|---|---|
| Mal5g3470 | - | - | gmx:100800024 | 499.59 |